Skip to content

Price / sales at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
4.4×-0.8×
Labcorp Holdings logo
Labcorp HoldingsLH
1.6×+0.1×
IQVIA logo
IQVIAIQV
1.7×-0.3×
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
0.6×+0.3×
Veeva Systems logo
Veeva SystemsVEEV
7.7×-5.3×
Arrowhead Research logo
Arrowhead ResearchARWR
14.1×+10.9×

Other financials

Income statement

See full
Revenue$706.6M+26.5%
Operating income$141.5M+24.6%
Net income$123.9M+8.1%
EPS (diluted)$4.28+16.6%

Balance sheet

See full
Cash & equivalents$652.7M+47.9%
Total debt$146.1M-2.8%
Total equity$598.3M+0.8%
Total assets$2.1B+12.2%

Cash flow

See full
Operating cash flow$151.8M+20.6%
CapEx$6.8M-31.8%
Free cash flow$145.0M+25.1%

Valuation

See full
Market cap$13.14B+46.8%
Enterprise value$12.64B+45.9%
P/E28.6×+7.0×

Profitability

See full
Operating margin21%-0.1pp
Net margin17.2%-2.1pp
FCF margin26.5%+1.5pp

Returns & leverage

See full
Return on equity77.3%+11.4pp
Debt / equity0.2×0.0×
Current ratio0.8×+0.1×

Where this comes from

Calculated from Medpace Holdings, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Medpace Holdings, Inc.’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medpace Holdings, Inc.'s price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medpace Holdings, Inc.'s price / sales?
Medpace Holdings, Inc. (MEDP) reported price / sales of 5.1× in Q1 2026.
How has Medpace Holdings, Inc.'s price / sales changed year-over-year?
Medpace Holdings, Inc.'s price / sales increased by 18.2% year-over-year, from 4.3× to 5.1×.
What is the long-term trend for Medpace Holdings, Inc.'s price / sales?
Over 5 years (2020 to 2025), Medpace Holdings, Inc.'s price / sales has grown at a 3.0% compound annual growth rate (CAGR), from 5.4× to 6.3×.
What does price / sales mean?
How many dollars investors pay for each dollar of the company's annual sales.
How do you interpret price / sales?
Useful when earnings are negative or volatile (e.g. early-stage or cyclical firms). Only comparable across companies with similar margins — a sales dollar is worth more at a high-margin business.
How does price / sales compare across companies?
Best compared within a margin cohort; a software P/S and a retailer P/S are not directly comparable.